Filing Flows › Atrium Therapeutics (RNA) › Recalls, complaints & regulation
Atrium Therapeutics (RNA): recalls and clinical trials
Atrium Therapeutics (RNA) beyond its filings: 3 recalls in the last 12 months (87 in five years, 2 Class I); 2 active clinical trials.
Latest recalls
- 2026-09-16 · FDA device · Getinge PVC Thoracic Catheter, Soft PVC Straight, 10 per Case; Size(Model Number): 1. 16FR(8016), 2. 24FR(8024), 3. 28FR(8028), 4. 32FR(8032), 5. 36FR(8036);
- 2026-09-16 · FDA device · Getinge PVC Thoracic Catheter, Firm PVC Straight, 10 per Case; Size(Model Number): 1. 28FR(15028), 2. 36FR(15036);
- 2026-09-16 · FDA device · Getinge PVC Thoracic Catheter, Soft PVC Right Angle, 10 per Case; Size(Model Number): 1. 24FR(8124), 2. 28FR(8128), 3. 32FR(8132), 4. 36FR(8136);
- 2024-10-16 · FDA device · iCast Covered Stent, 6MMx16MMx120CM, Model Number 42616
- 2024-06-12 · FDA device · ADVANTA VXT, 6X80, 1GDS, FH, STR-TW. Single-Ended Slider GDS. Vascular graft
- 2024-06-12 · FDA device · ADVANTA VXT, 6X70, 1GDS, FH, STR-TW. Single-Ended Slider GDS. Vascular graft
- 2024-06-12 · FDA device · ADVANTA VXT, 7X70, 1GDS, NH, STR-SW. Single-Ended Slider. Vascular graft
- 2024-06-12 · FDA device · ADVANTA VXT, 5X50, 1GDS, NH, STR-SW. Single-Ended Slider. Vascular graft
Atrium Therapeutics' latest quarter
Atrium Therapeutics, Q2 2026: revenue $3.0M (-22% year over year), operating margin -752.9%, net loss $20.2M, operating cash flow −$3.9M. The chart follows the revenue to costs, profit and cash.
Questions
Has Atrium Therapeutics had any recalls?
87 recalls on file over five years from the FDA, CPSC and NHTSA; 3 in the last 12 months.
How many clinical trials does Atrium Therapeutics have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.